Cera Sanitaryware
- Market cap
- ₹ 5,853 Cr.
- P/E
- 23.7x
- P/B
- 4.09x
- 52-week range
- 4,461.1 – 6,740
- ROE
- 15%
- ROCE
- 19%
- Dividend yield
- 1.6%
- Debt / equity
- 0.03
- Sector
- Consumer Durables
- Industry
- Sanitary Ware
- Listed on
- NSE, BSE
About
Cera Sanitaryware Limited is engaged in the business of manufacturing, selling, and trading of building products and is having nonconventional wind & solar power for captive use in the State of Gujarat. Its products and services include sanitaryware, faucets and showers, tiles, and wellness. Its Sanitaryware products include EWCs, wash basins, cisterns, seat covers, urinals, electronic flushing systems, special needs range, and bath accessories. Its Faucets & Showers products include foot operated faucets, single lever faucets, quarter turn faucets, half turn faucets, sensor and touch faucets, special-needed products, other allied products, health faucets, bathroom accessories and Cera auxiliaries. Its tile products include wall and floor tiles. Its Wellness products include a freestanding bathtub, a drop-in bathtub, air and water massage bathtub, shower panels, and others. Its kitchen sink products include handmade sinks, 304 grade SS sinks, and 202 grade SS sinks.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Sanitary Ware: 3 companies →Cera Sanitaryware against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)23.7 against a typical 40.5: cheaper than most peers (1st = cheapest).1st of 3
- Share price, 3 months−26.3% against a typical −25.3%.3rd of 3
- Size₹ 5,853.2 Cr. market value against a typical ₹ 1,332.3 Cr. (1st = largest).1st of 3
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
High safety
Rated AA by 2 agencies- All agencies agree and none has raised a warning.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CARE | CARE AA / CARE A1+ | Stable | 7 Sep 2026 |
| CRISIL | Crisil AA | Stable | 2 Jul 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 7 Sep 2026 | Reaffirmed | CARE AA / CARE A1+ | — | CARE | ₹ 100 Cr. | |
| 2 Jul 2026 | Reaffirmed | Crisil AA | — | CRISIL | ₹ 130 Cr. | |
| 21 Apr 2026 | Rating action | Crisil AA | — | CRISIL | ₹ 130 Cr. | |
| 26 Aug 2025 | Reaffirmed | CARE AA / CARE A1+ | — | CARE | ₹ 100 Cr. |
Research by Minerva Capital Research Solutions
Our research team's work on Cera SanitarywareAlso covered in
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 4 Nov 2026Upcoming | Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2026 and other business matters |
| 7 Aug 2026 | Financial Results | Board Meeting Intimation to Consider and Approve the Unaudited Financial Results for the Quarter ended 30th June, 2026. |
| 8 May 2026 | Financial Results/Dividend | Board Meeting Intimation for Consideration of Audited Financial Results of the Company for the Quarter and Year ended 31st March, 2026 and To Recommend Dividend, if any on Equity Shares for the FY 2025-26. |
| 4 Feb 2026 | Financial Results | The meeting of the Board of Directors of the Company is scheduled on 4th February, 2026 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter and nine months ended 31st December, 2025. |
| 11 Nov 2025 | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended 30th September, 2025 |
| 6 Aug 2025 | Financial Results | Board Meeting to be held on 6th August, 2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarter ended 30th June, 2025 |
| 9 May 2025 | Financial Results/Dividend | To consider and approve 1. Standalone and Consolidated Audited Financial Results for the Quarter and Year ended 31st March 2025. 2. To recommend Dividend, if any on Equity Shares for the Financial Year 2024-25. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 461 | 437 | 547 | 398 | 490 | 449 | 578 | 407 | 488 | 499 | 624 | 486 |
| Expenses | 387 | 377 | 455 | 342 | 420 | 390 | 472 | 354 | 421 | 448 | 526 | 437 |
| Operating Profit | 74 | 59 | 92 | 56 | 70 | 59 | 106 | 53 | 67 | 51 | 98 | 49 |
| OPM % | 16% | 14% | 17% | 14% | 14% | 13% | 18% | 13% | 14% | 10% | 16% | 10% |
| Other Income | 11 | 16 | 16 | 16 | 18 | 12 | 14 | 19 | 17 | −7 | 17 | 21 |
| Interest | 1 | 1 | 1 | 1 | 3 | 2 | 2 | 1 | 2 | 2 | 1 | 1 |
| Depreciation | 8 | 9 | 9 | 8 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 9 |
| Profit before tax | 76 | 65 | 98 | 63 | 75 | 60 | 108 | 61 | 72 | 32 | 104 | 60 |
| Tax % | 25% | 22% | 23% | 25% | 10% | 23% | 21% | 24% | 22% | 27% | 25% | 24% |
| Net Profit | 57 | 51 | 75 | 47 | 68 | 46 | 86 | 47 | 57 | 24 | 77 | 45 |
| EPS in Rs | 43.74 | 39.12 | 57.69 | 36.11 | 52.79 | 35.56 | 66.35 | 36.08 | 43.92 | 18.35 | 59.97 | 35.13 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 8%
- 5 Years
- 11%
- 3 Years
- 4%
- TTM
- 9%
- 10 Years
- 10%
- 5 Years
- 16%
- 3 Years
- −1%
- TTM
- −17%
- 10 Years
- 9%
- 5 Years
- 4%
- 3 Years
- −13%
- TTM
- —
- 10 Years
- 17%
- 5 Years
- 18%
- 3 Years
- 17%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Cera Sanitaryware | ₹ 4,450.50 | ₹ 5,853 Cr. | 23.7x | 4.1x | 15% | — |
| Grindwell Norton | ₹ 1,858.00 | ₹ 20,572 Cr. | 55.4x | 9.1x | 17.4% | 13.6% |
| Carborundum Universal | ₹ 1,031.30 | ₹ 19,647 Cr. | 71.3x | 5.2x | 5.2% | 3.2% |
| Kajaria Ceramics | ₹ 1,137.65 | ₹ 17,896 Cr. | 38x | 6.4x | 16.8% | 10.2% |
| Century Plyboards (India) | ₹ 636.25 | ₹ 14,165 Cr. | 65.9x | 6.8x | 10.6% | 5% |
| Jindal SAW | ₹ 233.30 | ₹ 14,864 Cr. | 17.4x | 1.4x | — | 3.3% |
Management
- Vikram Somany
- Chairman of the Board, Managing Director
- Vikas Kothari
- Chief Financial Officer
- Hemal Janardan Sadiwala
- Compliance Officer, Company Secretary
- Deepshikha Khaitan
- Joint Managing Director, Executive Director
- Anupam Gupta
- Executive Director - Technical
Prices are delayed and for information only. Nothing on this page is investment advice.